PepGen
PEPG
NASDAQ
IPO2022
about PEPG
PepGen is a biopharmaceutical company dedicated to developing peptide-based therapeutic platforms, specifically targeting rare diseases such as lysosomal disorders and neurodegenerative conditions with innovative treatments.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.90 | $6.34 | $4.90 | $87.25M | 117.84M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.70 | n/a | n/a | 0% | 0% | 0% |